Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Besnard

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Annales De Biologie Clinique|January 1, 1988
[Determination of plasma progesterone. Comparison of immunochemical luminescence (LIA) and radioimmunoassay (RIA)]D Guilloteau, E Petat, J C Besnard
European Journal of Nuclear Medicine|January 1, 1985
Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidineD Guilloteau, J L Baulieu, J C Besnard
Experimental Cell Research|November 1, 1989
Reversible extinction of insulin gene expression in insulinoma x fibroblast somatic cell hybridsC Besnard, P Lores, D Daegelen, et al.
Human Genetics|March 1, 1994
A new highly polymorphic DNA restriction site marker in the 5' region of the human tyrosine hydroxylase gene (TH) detecting loss of heterozygosity in human embryonal rhabdomyosarcomaC Besnard-Guérin, W K Cavenee, I Newsham
Cell Differentiation|December 1, 1984
Persistence of transcription of the human beta-globin gene in hybrids between transfected F9 embryonal carcinoma and L cellsC Besnard, C Lasserre, R Pictet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Plasma calcitonin and breast tumors]D Guilloteau, J L Baulieu, J C Besnard
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2022
[News in gastrointestinal radiotherapy: The esophageal cancer]L Quéro, C Besnard, S Guillerm, et al.
Genomics|February 1, 1994
Molecular sublocalization and characterization of the 11;22 translocation breakpoint in a malignant rhabdoid tumorI Newsham, D Daub, C Besnard-Guerin, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Spiperone: a receptor ligand and/or a granular uptake tracer?F Huguet, S Chalon, D Guilloteau, et al.
Revue Neurologique|November 1, 1976
[Diagnosis of cerebrovascular disorders using stannous technetium pyrophosphate]T Planiol, A Guillemart, J C Besnard, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Annales De Biologie Clinique|January 1, 1988
[Determination of plasma progesterone. Comparison of immunochemical luminescence (LIA) and radioimmunoassay (RIA)]D Guilloteau, E Petat, J C Besnard
European Journal of Nuclear Medicine|January 1, 1985
Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidineD Guilloteau, J L Baulieu, J C Besnard
Experimental Cell Research|November 1, 1989
Reversible extinction of insulin gene expression in insulinoma x fibroblast somatic cell hybridsC Besnard, P Lores, D Daegelen, et al.
Human Genetics|March 1, 1994
A new highly polymorphic DNA restriction site marker in the 5' region of the human tyrosine hydroxylase gene (TH) detecting loss of heterozygosity in human embryonal rhabdomyosarcomaC Besnard-Guérin, W K Cavenee, I Newsham
Cell Differentiation|December 1, 1984
Persistence of transcription of the human beta-globin gene in hybrids between transfected F9 embryonal carcinoma and L cellsC Besnard, C Lasserre, R Pictet, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Plasma calcitonin and breast tumors]D Guilloteau, J L Baulieu, J C Besnard
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 8, 2022
[News in gastrointestinal radiotherapy: The esophageal cancer]L Quéro, C Besnard, S Guillerm, et al.
Genomics|February 1, 1994
Molecular sublocalization and characterization of the 11;22 translocation breakpoint in a malignant rhabdoid tumorI Newsham, D Daub, C Besnard-Guerin, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Spiperone: a receptor ligand and/or a granular uptake tracer?F Huguet, S Chalon, D Guilloteau, et al.
Revue Neurologique|November 1, 1976
[Diagnosis of cerebrovascular disorders using stannous technetium pyrophosphate]T Planiol, A Guillemart, J C Besnard, et al.
Pageof 12